Shafia Rahman
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Oncology 16
- Pancreatic and Hepatic Oncology Research 6
- CAR-T cell therapy research 3
- COVID-19 and healthcare impacts 3
-
- Complement system in diseases 4
- T-cell and Retrovirus Studies 3
- Co-authors
- Jesus D. Gonzalez‐Lugo (5 shared papers)Henny Heisler Billett (3 shared papers)James M. Szymanski (3 shared papers)Morayma Reyes Gil (3 shared papers)Kenji Ikemura (2 shared papers)Yungtai Lo (2 shared papers)Margarita Kushnir (1 shared paper)Eran Y. Bellin (1 shared paper)
- Journals
- Blood (4 papers)Cancers (3 papers)Thrombosis Research (1 paper)JAMA Network Open (1 paper)Journal of Racial and Ethnic Health Disparities (1 paper)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Shafia Rahman
28 papers receiving 662 citations
Shafia Rahman's Hit Papers
Peers
Comparison fields: 5 of 74
- Infectious Diseases 320
- Internal Medicine 39
- Oncology 199
- Drug Discovery 1
- Neurology 72
Countries citing papers authored by Shafia Rahman
This map shows the geographic impact of Shafia Rahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shafia Rahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shafia Rahman more than expected).
Fields of papers citing papers by Shafia Rahman
This network shows the impact of papers produced by Shafia Rahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shafia Rahman. The network helps show where Shafia Rahman may publish in the future.
Co-authors
The 25 scholars most cited alongside Shafia Rahman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Seroconversion rates following COVID-19 vaccination among patients with cancer Hit paper breakdown → | 2021 | 266 |
| 2 | 2020 | 128 | |
| 3 | 2020 | 74 | |
| 4 | 2021 | 30 | |
| 5 | Multiple myeloma masquerading as a pituitary tumor. | 1977 | 27 |
| 6 | 2019 | 20 | |
| 7 | 2020 | 17 | |
| 8 | Assessment of the community clinics: effects on service delivery, quality and utilization of services | 2006 | 16 |
| 9 | 2021 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2023 | 12 | |
| 12 | 2021 | 10 | |
| 13 | 2023 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2018 | 3 | |
| 20 | 2020 | 3 |
About Shafia Rahman
Shafia Rahman is a scholar working on Oncology, Immunology, Infectious Diseases, Genetics and Internal Medicine, having authored 35 papers that have together received 681 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Complement system in diseases (4 papers), Cancer Genomics and Diagnostics (3 papers), CAR-T cell therapy research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), T-cell and Retrovirus Studies (3 papers) and COVID-19 and healthcare impacts (3 papers). The work is most often cited by research in Infectious Diseases (320 citations), Internal Medicine (39 citations), Oncology (199 citations), Drug Discovery (1 citation) and Neurology (72 citations). Shafia Rahman has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Jesus D. Gonzalez‐Lugo, Henny Heisler Billett, James M. Szymanski, Morayma Reyes Gil, Kenji Ikemura, Yungtai Lo, Margarita Kushnir, Eran Y. Bellin, Ladan Golestaneh and Charles E. M. Normand. Their work appears in journals such as Blood, Cancers, Thrombosis Research, JAMA Network Open and Journal of Racial and Ethnic Health Disparities.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.